JP7454589B2 - セロトニン５－ｈｔ２ｂ阻害化合物 - Google Patents
セロトニン５－ｈｔ２ｂ阻害化合物 Download PDFInfo
- Publication number
- JP7454589B2 JP7454589B2 JP2021557368A JP2021557368A JP7454589B2 JP 7454589 B2 JP7454589 B2 JP 7454589B2 JP 2021557368 A JP2021557368 A JP 2021557368A JP 2021557368 A JP2021557368 A JP 2021557368A JP 7454589 B2 JP7454589 B2 JP 7454589B2
- Authority
- JP
- Japan
- Prior art keywords
- imidazol
- methanone
- piperidin
- phenyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825051P | 2019-03-28 | 2019-03-28 | |
| US62/825,051 | 2019-03-28 | ||
| PCT/US2020/024969 WO2020198478A1 (en) | 2019-03-28 | 2020-03-26 | Serotonin 5-ht2b inhibitory compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527080A JP2022527080A (ja) | 2022-05-30 |
| JP2022527080A5 JP2022527080A5 (https=) | 2022-10-25 |
| JP7454589B2 true JP7454589B2 (ja) | 2024-03-22 |
Family
ID=70775466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557368A Active JP7454589B2 (ja) | 2019-03-28 | 2020-03-26 | セロトニン５－ｈｔ２ｂ阻害化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12240827B2 (https=) |
| EP (1) | EP3947360B1 (https=) |
| JP (1) | JP7454589B2 (https=) |
| CN (1) | CN113631548B (https=) |
| AU (1) | AU2020245614B2 (https=) |
| BR (1) | BR112021019314A2 (https=) |
| CA (1) | CA3134952C (https=) |
| DK (1) | DK3947360T3 (https=) |
| ES (1) | ES2991167T3 (https=) |
| FI (1) | FI3947360T3 (https=) |
| PL (1) | PL3947360T3 (https=) |
| PT (1) | PT3947360T (https=) |
| WO (1) | WO2020198478A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240027076A (ko) * | 2021-07-26 | 2024-02-29 | 조에티스 서비시즈 엘엘씨 | 세로토닌 5-ht2b 억제 화합물 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007097197A1 (ja) | 2006-02-20 | 2007-08-30 | Astellas Pharma Inc. | アミド誘導体またはその塩 |
| JP2012512877A (ja) | 2008-12-18 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | セロトニン５−ｈｔ２ｂ受容体阻害剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0515995D0 (en) | 2005-08-03 | 2005-09-07 | Sandoz Ag | Organic compounds |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 |
| US8697739B2 (en) | 2010-07-29 | 2014-04-15 | Novartis Ag | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof |
-
2020
- 2020-03-26 PL PL20726982.0T patent/PL3947360T3/pl unknown
- 2020-03-26 US US17/441,340 patent/US12240827B2/en active Active
- 2020-03-26 EP EP20726982.0A patent/EP3947360B1/en active Active
- 2020-03-26 JP JP2021557368A patent/JP7454589B2/ja active Active
- 2020-03-26 PT PT207269820T patent/PT3947360T/pt unknown
- 2020-03-26 ES ES20726982T patent/ES2991167T3/es active Active
- 2020-03-26 FI FIEP20726982.0T patent/FI3947360T3/fi active
- 2020-03-26 WO PCT/US2020/024969 patent/WO2020198478A1/en not_active Ceased
- 2020-03-26 AU AU2020245614A patent/AU2020245614B2/en active Active
- 2020-03-26 CN CN202080024800.0A patent/CN113631548B/zh active Active
- 2020-03-26 DK DK20726982.0T patent/DK3947360T3/da active
- 2020-03-26 BR BR112021019314A patent/BR112021019314A2/pt unknown
- 2020-03-26 CA CA3134952A patent/CA3134952C/en active Active
-
2025
- 2025-01-21 US US19/032,924 patent/US20250179046A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007097197A1 (ja) | 2006-02-20 | 2007-08-30 | Astellas Pharma Inc. | アミド誘導体またはその塩 |
| JP2012512877A (ja) | 2008-12-18 | 2012-06-07 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | セロトニン５−ｈｔ２ｂ受容体阻害剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220162183A1 (en) | 2022-05-26 |
| US12240827B2 (en) | 2025-03-04 |
| PL3947360T3 (pl) | 2024-11-04 |
| CA3134952A1 (en) | 2020-10-01 |
| EP3947360A1 (en) | 2022-02-09 |
| AU2020245614A1 (en) | 2021-10-14 |
| US20250179046A1 (en) | 2025-06-05 |
| JP2022527080A (ja) | 2022-05-30 |
| DK3947360T3 (da) | 2024-08-26 |
| WO2020198478A8 (en) | 2021-09-16 |
| ES2991167T3 (es) | 2024-12-02 |
| CA3134952C (en) | 2023-08-08 |
| BR112021019314A2 (pt) | 2021-12-14 |
| CN113631548A (zh) | 2021-11-09 |
| FI3947360T3 (fi) | 2024-10-07 |
| CN113631548B (zh) | 2023-06-06 |
| EP3947360B1 (en) | 2024-08-07 |
| WO2020198478A1 (en) | 2020-10-01 |
| AU2020245614B2 (en) | 2023-01-19 |
| PT3947360T (pt) | 2024-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101679244B (zh) | 5元杂环衍生物及其医药用途 | |
| CN102224142B (zh) | 具有5-ht2b受体拮抗活性的新型吡唑-3-羧酰胺衍生物 | |
| US5128359A (en) | Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation | |
| KR20200020781A (ko) | S1p1 활성을 조정하기 위한 화합물 및 그를 사용하는 방법 | |
| US20030114683A1 (en) | Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors | |
| DE60108633T2 (de) | 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin v1b und v1a rezeptoren | |
| BR112015012555B1 (pt) | Derivados de benzimidazol, seus usos, e medicamentos | |
| BG100547A (bg) | Заместени n-(индол-2-карбонил) глицинамиди и техни производни като противодиабетични средства | |
| US6596732B2 (en) | 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same | |
| US20030139413A1 (en) | Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them | |
| JP2008526702A (ja) | 置換オキシインドール誘導体、該誘導体を含んでいる薬物及びそれらの使用 | |
| EP2265582A1 (fr) | Nouveaux derives de 3-aminoalkyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique. | |
| JP2004517822A (ja) | 治療分子および方法 | |
| US20250179046A1 (en) | Serotonin 5-ht2b inhibitory compounds | |
| JPWO2006075638A1 (ja) | 新規ヘテロアリール誘導体 | |
| JP7696490B2 (ja) | セロトニン５－ｈｔ２ｂ阻害化合物 | |
| CN119143734A (zh) | 作为at2r拮抗剂的杂环化合物及其用途 | |
| HK40059048A (en) | Serotonin 5-ht2b inhibitory compounds | |
| HK40059048B (en) | Serotonin 5-ht2b inhibitory compounds | |
| JP2010155802A (ja) | ５−ｈｔ２ｂ受容体拮抗活性を有する新規５−エチニルピラゾール−３−カルボキサミド誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210930 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221017 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221017 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20231012 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231106 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240206 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240308 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240311 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7454589 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |